Roche chairman sees greater flexibility after Novartis deal - paper - NewsBreak

ZURICH, Nov 6 (Reuters) - Roche's (ROG.S) $20.7 billion move to buy back nearly a third of its voting stock from fellow Swiss drugmaker Novartis (NOVN.S) will give it more strategic flexibility, Chairman Christoph Franz said in an interview published on Saturday. The deal, announced on Thursday, extricates Roche from...